136 related articles for article (PubMed ID: 36052754)
1. Refractory pemphigus vulgaris and high-intensity extracorporeal photopheresis: A case report.
Castillo-Aleman YM; Bencomo-Hernandez AA; Ventura-Carmenate Y; Villegas-Valverde CA; Rivero-Jimenez RA;
Photodermatol Photoimmunol Photomed; 2022 Sep; ():. PubMed ID: 36052754
[TBL] [Abstract][Full Text] [Related]
2. Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases.
Wollina U; Lange D; Looks A
Dermatology; 1999; 198(2):140-4. PubMed ID: 10325460
[TBL] [Abstract][Full Text] [Related]
3. [Extracorporeal photopheresis in therapy-refractory disseminated discoid lupus erythematosus].
Richter HI; Krutmann J; Goerz G
Hautarzt; 1998 Jun; 49(6):487-91. PubMed ID: 9675577
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis: from solid organs to face transplantation.
Hivelin M; Siemionow M; Grimbert P; Lantieri L
Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases].
Owsianowski M; Garbe C; Ramaker J; Orfanos CE; Gollnick H
Hautarzt; 1996 Feb; 47(2):114-23. PubMed ID: 8868455
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
Richet C; Huynh A; Dimeglio C; Borel C; Lepage B; Boulinguez S; Marguery MC; Paul C; Bulai Livideanu C
Dermatology; 2018; 234(1-2):23-30. PubMed ID: 29788024
[TBL] [Abstract][Full Text] [Related]
7. The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.
Alsuliman T; Magro L; Coiteux V; Gauthier J; Srour M; Lionet A; Beauvais D; Yakoub-Agha I
Curr Res Transl Med; 2020 Apr; 68(2):71-76. PubMed ID: 31631014
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photopheresis as a therapy for autoimmune diseases.
Kuzmina Z; Stroncek D; Pavletic SZ
J Clin Apher; 2015 Aug; 30(4):224-37. PubMed ID: 25546289
[TBL] [Abstract][Full Text] [Related]
9. Remission of severe autoimmune bullous disorders induced by long-term extracorporeal photochemotherapy.
Sanli H; Akay BN; Ayyildiz E; Anadolu R; Ilhan O
Transfus Apher Sci; 2010 Dec; 43(3):353-359. PubMed ID: 21035398
[TBL] [Abstract][Full Text] [Related]
10. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photopheresis: a review on the immunological aspects and clinical applications.
Chiesa-Fuxench ZC; González-Chávez J
P R Health Sci J; 2010 Dec; 29(4):337-47. PubMed ID: 21261172
[TBL] [Abstract][Full Text] [Related]
12. Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Andreu-Ullrich H
Transfus Apher Sci; 2014 Jun; 50(3):363-9. PubMed ID: 24816437
[TBL] [Abstract][Full Text] [Related]
13. Localized CO
Chainani-Wu N; Gopal-Murthy V; Wu A; Marinkovich MP
Clin Adv Periodontics; 2023 Mar; 13(1):38-41. PubMed ID: 35649436
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD.
Dignan FL; Greenblatt D; Cox M; Cavenagh J; Oakervee H; Apperley JF; Fielding AK; Pagliuca A; Mufti G; Raj K; Marks DI; Amrolia P; Peniket A; Medd P; Potter MN; Shaw BE; Scarisbrick JJ
Bone Marrow Transplant; 2012 Jun; 47(6):824-30. PubMed ID: 21927038
[TBL] [Abstract][Full Text] [Related]
15. Single-center experience with extracorporeal photopheresis in pediatric heart transplantation.
Carlo WF; Pearce FB; George JF; Tallaj JA; McGiffin DC; Marques MB; Adamski J; Kirklin JK
J Heart Lung Transplant; 2014 Jun; 33(6):624-8. PubMed ID: 24661684
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
Worel N; Lehner E; Führer H; Kalhs P; Rabitsch W; Mitterbauer M; Hopfinger G; Greinix HT
Transfusion; 2018 Apr; 58(4):1045-1053. PubMed ID: 29446444
[TBL] [Abstract][Full Text] [Related]
17. Novel therapies for pemphigus vulgaris: an overview.
Perez OA; Patton T
Drugs Aging; 2009; 26(10):833-46. PubMed ID: 19761276
[TBL] [Abstract][Full Text] [Related]
18. Successful reversal of recalcitrant hepatic allograft rejection by photopheresis.
Lehrer MS; Ruchelli E; Olthoff KM; French LE; Rook AH
Liver Transpl; 2000 Sep; 6(5):644-7. PubMed ID: 10980066
[TBL] [Abstract][Full Text] [Related]
19. A Novel Combined Use of Dupilumab for Treatment of Aggressive Refractory Pemphigus Vulgaris Complicated With Pulmonary Tuberculosis: A Case Report and the RNA-seq Analysis.
Chen S; Zhan S; Hua C; Tang Y; Cheng H
Front Immunol; 2022; 13():825796. PubMed ID: 35222408
[TBL] [Abstract][Full Text] [Related]
20. [Extracorporeal photochemotherapy in therapy-refractory subacute lupus].
Richard MA; Saadallah S; Lefevre P; Poullin P; Buscaylet S; Grob JJ
Ann Dermatol Venereol; 2002; 129(8-9):1023-6. PubMed ID: 12442100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
